Macular Degeneration Foundation believes a cap on the Medicare item number for the treatment of wet AMD should have minimal impact on patients.
Read MoreMacular Degeneration Foundation believes a cap on the Medicare item number for the treatment of wet AMD should have minimal impact on patients.
Read MoreThe TGA has approved a new drug, Eylea, for the treatment of wet (neovascular) age-related macular degeneration.
Read MoreABC to trial audio description on television to assist people who are blind or visually impaired.
Read MoreDame Judi Dench has revealed a diagnosis of age-related macular degeneration.
Read MoreThe federal government has heard and acknowledged the Foundation’s postcard campaign for increased funding.
Read MoreWe reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.
Read MoreThe inaugural Macular Degeneration Foundation Research Grants Program awarded nearly three-quarters of a million dollars to support crucial macular disease research.
Read MoreThe 2011 Eyes on the Future report provides the most comprehensive compilation of macular degeneration statistics and research ever undertaken in Australia.
Read MoreThere is no compelling evidence-based research that hyperbaric oxygen treatment has a beneficial effect on AMD.
Read More